Leysen L, Marticic Giljevic K, Piccinin C, Shkodra M, Pe M, Petersen M, Apolone G, Brunelli C, Lombardo C, Velikova G, Gilbert A, Pravettoni G, Ciliberto G, Groenvold M, Ferrer M, Bos N, Pietrobon R, Couespel N, Caraceni A, Guren M, Sirven A, Vachon H, EUonQOL consortium(2025) Evaluation of the psychometric properties of patient-reported outcome measures of health-related quality of life across the European cancer continuum: a systematic review protocol using COSMIN methodology BMJ Open, 15(3), e088716 DOI 10.1136/bmjopen-2024-088716, PubMed 40157731
Cilla S, Rossi R, Donati CM, Habberstad R, Klepstad P, Dall'Agata M, Valenti V, Kaasa S, Medici F, Morganti AG, Maltoni M(2025) Pain Management Adequacy in Patients With Bone Metastases: A Secondary Analysis From the Palliative Radiotherapy and Inflammation Study Trial Clin Med Insights Oncol, 19, 11795549241297054 DOI 10.1177/11795549241297054, PubMed 40144780
Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H(2025) Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial Br J Cancer(in press) DOI 10.1038/s41416-025-02983-w, PubMed 40133509